From off-the-shelf CAR T-cell therapy products, a big focus on drug-antibody conjugates and novel molecular compound trials to the search for new immunotherapy regimens we talk to HSANZ president Dr Leanne Berkahn about what 2021 will bring to the field of haematology.
We’re now available on iTunes – to listen from your podcast app search for the limbic or click here from your mobile device.